August 08, 2016
The event technology platform plans to integrate a conference note-taking app developed by AstraZeneca and DigitasLBi.
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy